An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
Ilias Houda(Amsterdam University Medical Centers), Lizza Hendriks(Maastricht University), Thierry Berghmans(Institut Jules Bordet), Mariana Brandão(Institut Jules Bordet), Corinne Faivre‐Finn(University of Manchester), Yassin Pretzenbacher(European Organisation for Research and Treatment of Cancer), Anne‐Marie C. Dingemans(Erasmus MC Cancer Institute), Matthias Gückenberger(University Hospital of Zurich), Benjamin Besse(Institut Gustave Roussy), John Edwards(Sheffield Teaching Hospitals NHS Foundation Trust), Sanjay Popat(Royal Marsden NHS Foundation Trust), Laura Moliner(Institut Català d'Oncologia), Paul Van Schil(Antwerp University Hospital), Jordi Remón(Vall d'Hebron Hospital Universitari), Alessio Vincenzo Mariolo(Institute Mutualiste Montsouris), Marco Tagliamento(Ospedale Policlinico San Martino), Idris Bahce(Amsterdam Neuroscience), Stephanie Kroeze(University Hospital of Zurich), Torsten Blum(MSB Medical School Berlin), Tiuri E. Kroese(University of Zurich), Alessandro Brunelli(St James's University Hospital), Isabelle Opitz(University Hospital of Zurich), Dirk De Ruysscher(Maastricht University Medical Centre), Chris Dickhoff(Amsterdam Neuroscience)
Cited by 53
Related Papers
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
|New England Journal of Medicine|2007|1.1k